A University of Minnesota research team earned a $11.6 million grant to work with the Mayo Clinic on a device designed to ...

The US Food and Drug Administration (FDA) has designated Celltrion’s Yuflyma (adalimumab-aaty) as an interchangeable biosimilar to AbbVie’s Humira (adalimumab). The decision allows Yuflyma to be ...

The risk for inflammatory bowel disease is higher in patients with psoriasis or ankylosing spondylitis using IL-17A inhibitors than in those using apremilast, necessitating careful patient monitoring.

The University of Central Lancashire is co-leading the first and largest human trial of its kind. A study found that patients with mild-to-moderate ulcerative colitis who drank 130ml of diluted Montmo ...

Irritable bowel syndrome (IBS) can mimic some symptoms of inflammatory bowel disease (IBD). Learn how their causes, diagnosis ...

Sociodemographic and psychosocial characteristics predict readmission within 90 days among patients with ulcerative colitis or Crohn disease.

The longtime Oriole has been a huge part of the team's resurgence. But he's also a free agent-to-be with potential in-house ...

Natalie Hayden was a young adult when she was diagnosed with Crohn's disease. Her mom once again became her caregiver.

Fact checked by Nick Blackmer As a parent, one of your greatest fears is having your child be diagnosed with a life-long ...

DUBAI, 16th April 2025 (WAM) -- The Emirates Drug Establishment (EDE) has approved new indications for Guselkumab, making the UAE the second country globally to authorise the treatment for Crohn’s ...

With the introduction of a subcutaneous formulation, ENTYVIO has expanded patient convenience and global accessibility. Continued growth is s ...